Pfizer's Announced The Launch Of Trastuzumab Biosimilar For Global Herceptin Biosimilar Market

 

Herceptin Biosimilar Market

The growing prevalence of cancers such as breast cancer in women is driving the growth of the global Herceptin biosimilar market. According to the World Health Organization’s report published in 2019, approximately 627,000 women across the globe died from breast cancer and it accounted for around 15% of all cancer deaths among women in 2018. Also, the rising prevalence of gastric cancers such as metastatic gastric cancer is again contributing to the growth of the Herceptin biosimilar market. According to the US National Library of Medicine’s report published in 2018, gastric cancer is the fifth most common neoplasm in people and the third most deadly cancer across the globe. According to the same source, gastric cancer accounted for around 783,000 death globally in 2018.

Key players engaged in the global Herceptin biosimilar market include AryoGen Biopharma, Amgen Inc.,  Biocon Limited,  Pfizer Inc., Merck & Co., Inc., Celltrion Inc., Accord Healthcare Ltd, Gedeon Richter Plc, Genor Biopharma Company Ltd, Mabion SA, Mylan N.V, Roche Holding AG and Samsungbioepis Co,.Ltd

North America is expected to lead the global Herceptin biosimilar market due to the increasing number of companies focusing on obtaining approvals and launching products for the treatment of cancers such as gastric cancer and breast cancer. For instance, in 2019, Amgen Inc. and Allergan collaboratively launched KANJINTI (trastuzumab) for treatment of HER2-overexpressing adjuvant and metastatic breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. KANJINTI received approval from the U.S. Food Drug and Administration and can be used for the treatment of breast cancer and gastric cancer throughout the U.S.

1.      In February 2020, Pfizer's announced the launch of trastuzumab biosimilar to Herceptin. Trazimera is available for the treatment of human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma

2.      In April 2020, Merck began its US launch of the trastuzumab biosimilar Ontruzant at a 15% discount to the biologic medicine Herceptin

3.      In June 2019, The US Food and Drug Administration (FDA) approved Amgen’s Kanjinti (trastuzumab-anns), which is the fifth biosimilar to be approved for Roche’s Herceptin (trastuzumab) and 20th biosimilar overall

Herceptin Biosimilar is a new combination drug that has been formulated to treat different types of cancers. The main active component is Herceptin, which acts on the promoters of collagen and elastin production in the body. Herceptin Biosimilar has been clinically proven to reduce breast tumor size in women with breast cancer that had not responded to hormonal therapy alone. This drug has also been found to be effective in reducing the size of ovarian tumors in men.

Comments

Post a Comment

Popular posts from this blog

Global Video Event Data Recorder Market Continues To Grow Owing To the Increased Demand from the Automobile Sector and Stringent Road Safety Measures Taken By Governmental Bodies across the World

Image
  Video event data recorder (VEDR) is a device that captures and stores the data from live events such as seminars, meetings, product demonstrations, trade shows, presentations, conventions, training programs, live concerts, and events that use sophisticated optics and light systems to create the video images at a recording-quality level. The devices can record the full duration of any event. VEDRs are integrated with advanced event management solutions that utilize advanced monitoring and reporting features to track, manage and analyze the captured data. Some systems also allow users to upload content directly from their computers or smartphones to multiple different locations and devices. Market Dynamics                                                The latest video event data recorders from leading brands like Canon, Casio, Fuji, Samsung, Olympus, Panasonic, Pentax, Samsung, Voip, Apple, Blackberry, and PIXA are all designed to improve the quality of video capture. The newest p
Read more

Astrum Has Expanded Its Presence In India Infrared Thermometer Market

Image
  The Infrared Thermometer market is witnessing the fastest growth in the Asia Pacific region and this can be accredited to the growing aging population in the region which is driving demand for healthcare services. Japan has the highest growing aging population in the country. According to the Statistics Bureau, Ministry of Internal Affairs and Communications, in 2019, the aged population (65 years old and over) was 35.89 million, constituting 28.4 percent of the total population (i.e., 1 in every 4 persons) and marking a record high in Japan. The rise in prevalence of infectious disease and increase in the demand for the product for newborns as children cannot hold the contact thermometer is playing a key role in the overall development of the infrared thermometer market . According to the World Health Organization, HIV, tuberculosis, malaria, neglected tropical diseases, and viral hepatitis affects billions of people around the world and causes more than 4 million deaths each year
Read more

Increasing Demand for Processed Food and Initiatives to Challenges Assumptions about Monosodium Glutamate to Augment Growth of Monosodium Glutamate Market

Image
  Monosodium Glutamate (MSG) is one of the most widely used food-additives in commercial foods. Market Dynamics Increasing demand for processed food is expected to propel growth of the global monosodium glutamate market. For instance, according to the U.S Department of Agriculture, export of prepared food from U.S. increased from US$ 5, 849 million in 2015 to US$ 6,682 million in 2019. Moreover, increasing sales in the restaurant sector is also expected to aid in growth of the market. For instance, according to The National Restaurant Association, restaurant sales are expected to value US$ 863 billion in 2019 in the U.S., witnessing an increase of 3.6% from 2018. Initiatives to challenges assumptions about monosodium glutamate are expected to offer lucrative growth opportunities for players in the global monosodium glutamate market . For instance, in December 2020, Ajinomoto Co., Inc. announced a new campaign to address the heart of MSG’s perception problem in the U.S. Moreover,
Read more